1.Zoller H, Wolf M, Blumenstein I et al. Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial. Gut 2022;0:1-10.
If you want to discuss in more detail about the study material, please reach out to our local medical team.
You are now leaving the Pharmacosmos Nordic website. The website you are about to visit is Pharmacosmos Headquarter or one of our subsidiaries.
Do you wish to continue.